Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16,900
Closed -$4.87M 343
2023
Q4
$4.87M Buy
16,900
+2,200
+15% +$599K 0.18% 47
2023
Q3
$3.95M Buy
14,700
+4,800
+48% +$1.2M 0.3% 47
2023
Q2
$2.2M Sell
9,900
-1,400
-12% -$325K 0.11% 78
2023
Q1
$2.73M Buy
11,300
+5,600
+98% +$1.37M 0.07% 80
2022
Q4
$1.5M Buy
+5,700
New +$1.53M 0.15% 127

Other funds holding AMGN

XR Securities's AMGN Position: Q2 2024 in Review

XR Securities sold out of Amgen (AMGN) in Q2 2024, closing a stake of 14,357 shares — an estimated $4.22M sold.

XR Securities first reported a position in AMGN in Q2 2018 and held it in 8 quarters. The position peaked at $4.08M in Q1 2024. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • XR Securities reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • XR Securities sold 14,357 Amgen shares in Q2 2024, an estimated $4.22M.
  • XR Securities first reported a position in Amgen in Q2 2018 and held it in 8 quarters.
  • XR Securities's Amgen position peaked at $4.08M in Q1 2024.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on XR Securities's 13F filing for Q2 2024, filed 5 Aug 2024.